United States · FDA National Drug Code directory
MICAFUNGIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67184-0589_0f106cca-1588-4f13-a833-662676fc85c8
- Product NDC
- 67184-0589
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Micafungin
- Labeler
- Qilu Pharmaceutical Co., Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250403
- Source listing expiry
- 20271231
Source-listed ingredients
- MICAFUNGIN — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (67184-0589-1) / 5 mL in 1 VIAL · 67184-0589-1
- 10 VIAL in 1 CARTON (67184-0589-2) / 5 mL in 1 VIAL · 67184-0589-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →